These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

217 related items for PubMed ID: 37371938

  • 1. Cardioprotective Effects of Dexmedetomidine in an Oxidative-Stress In Vitro Model of Neonatal Rat Cardiomyocytes.
    Borger M, von Haefen C, Bührer C, Endesfelder S.
    Antioxidants (Basel); 2023 Jun 02; 12(6):. PubMed ID: 37371938
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Dexmedetomidine at a dose of 1 µM attenuates H9c2 cardiomyocyte injury under 3 h of hypoxia exposure and 3 h of reoxygenation through the inhibition of endoplasmic reticulum stress.
    Zhu Z, Ling X, Zhou H, Zhang C.
    Exp Ther Med; 2021 Feb 02; 21(2):132. PubMed ID: 33376514
    [Abstract] [Full Text] [Related]

  • 4. Dexmedetomidine attenuates hypoxia-induced cardiomyocyte injury by promoting telomere/telomerase activity: Possible involvement of ERK1/2-Nrf2 signaling pathway.
    Wu W, Du Z, Wu L.
    Cell Biol Int; 2022 Jul 02; 46(7):1036-1046. PubMed ID: 35312207
    [Abstract] [Full Text] [Related]

  • 5. Dexmedetomidine reversed hypoxia/reoxygenation injury-induced oxidative stress and endoplasmic reticulum stress-dependent apoptosis of cardiomyocytes via SIRT1/CHOP signaling pathway.
    Zhang Y, Zhao Q, Li X, Ji F.
    Mol Cell Biochem; 2021 Jul 02; 476(7):2803-2812. PubMed ID: 33725228
    [Abstract] [Full Text] [Related]

  • 6. Dexmedetomidine protects cardiomyocytes against hypoxia/reoxygenation injury via multiple mechanisms.
    Cai S, Liu Y, Cheng Y, Yuan J, Fang J.
    J Clin Lab Anal; 2022 Jul 02; 36(7):e24119. PubMed ID: 34882841
    [Abstract] [Full Text] [Related]

  • 7. Dexmedetomidine alleviates H2O2-induced oxidative stress and cell necroptosis through activating of α2-adrenoceptor in H9C2 cells.
    Yin W, Wang C, Peng Y, Yuan W, Zhang Z, Liu H, Xia Z, Ren C, Qian J.
    Mol Biol Rep; 2020 May 02; 47(5):3629-3639. PubMed ID: 32342432
    [Abstract] [Full Text] [Related]

  • 8. Dexmedetomidine protects H9c2 cardiomyocytes against oxygen-glucose deprivation/reoxygenation-induced intracellular calcium overload and apoptosis through regulating FKBP12.6/RyR2 signaling.
    Yuan M, Meng XW, Ma J, Liu H, Song SY, Chen QC, Liu HY, Zhang J, Song N, Ji FH, Peng K.
    Drug Des Devel Ther; 2019 May 02; 13():3137-3149. PubMed ID: 31564830
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. FoxO4 negatively modulates USP10 transcription to aggravate the apoptosis and oxidative stress of hypoxia/reoxygenation-induced cardiomyocytes by regulating the Hippo/YAP pathway.
    Huang J, Liu Y, Wang M, Wang R, Ling H, Yang Y.
    J Bioenerg Biomembr; 2021 Oct 02; 53(5):541-551. PubMed ID: 34251583
    [Abstract] [Full Text] [Related]

  • 11. Dexmedetomidine-mediated regulation of miR-17-3p in H9C2 cells after hypoxia/reoxygenation injury.
    Yuan T, Yang Z, Xian S, Chen Y, Wang L, Chen W, Long W, Che Y.
    Exp Ther Med; 2020 Aug 02; 20(2):917-925. PubMed ID: 32742334
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Dexmedetomidine prevents septic myocardial dysfunction in rats via activation of α7nAChR and PI3K/Akt- mediated autophagy.
    Yu T, Liu D, Gao M, Yang P, Zhang M, Song F, Zhang X, Liu Y.
    Biomed Pharmacother; 2019 Dec 02; 120():109231. PubMed ID: 31546082
    [Abstract] [Full Text] [Related]

  • 14. An α2-adrenoceptor agonist: Dexmedetomidine induces protective cardiomyocyte hypertrophy through mitochondrial-AMPK pathway.
    Weng X, Liu H, Zhang X, Sun Q, Li C, Gu M, Xu Y, Li S, Li W, Du J.
    Int J Med Sci; 2020 Dec 02; 17(16):2454-2467. PubMed ID: 33029088
    [Abstract] [Full Text] [Related]

  • 15. Dexmedetomidine protects H9C2 rat cardiomyocytes against hypoxia/reoxygenation injury by regulating the long non-coding RNA colon cancer-associated transcript 1/microRNA-8063/Wnt/β-catenin axis.
    Liu C, Xu R.
    Bioengineered; 2022 May 02; 13(5):13300-13311. PubMed ID: 35635079
    [Abstract] [Full Text] [Related]

  • 16. Dexmedetomidine Alleviates Hyperoxia-Induced Acute Lung Injury via Inhibiting NLRP3 Inflammasome Activation.
    Zhang Q, Wu D, Yang Y, Liu T, Liu H.
    Cell Physiol Biochem; 2017 May 02; 42(5):1907-1919. PubMed ID: 28873369
    [Abstract] [Full Text] [Related]

  • 17. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH, Jin MM, Liu JT.
    Biomed Pharmacother; 2020 Jul 02; 127():110188. PubMed ID: 32407987
    [Abstract] [Full Text] [Related]

  • 18. Hypoxic preconditioning protects cardiomyocytes against hypoxia/reoxygenation-induced cell apoptosis via sphingosine kinase 2 and FAK/AKT pathway.
    Zhang R, Li L, Yuan L, Zhao M.
    Exp Mol Pathol; 2016 Feb 02; 100(1):51-8. PubMed ID: 26621495
    [Abstract] [Full Text] [Related]

  • 19. Dexmedetomidine Protects against Myocardial Ischemia/Reperfusion Injury by Ameliorating Oxidative Stress and Cell Apoptosis through the Trx1-Dependent Akt Pathway.
    Wu ZL, Davis JRJ, Zhu Y.
    Biomed Res Int; 2020 Feb 02; 2020():8979270. PubMed ID: 33299886
    [Abstract] [Full Text] [Related]

  • 20. Dexmedetomidine alleviates hepatic injury via the inhibition of oxidative stress and activation of the Nrf2/HO-1 signaling pathway.
    Zhao Y, Kong GY, Pei WM, Zhou B, Zhang QQ, Pan BB.
    Eur Cytokine Netw; 2019 Sep 01; 30(3):88-97. PubMed ID: 31957703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.